Skip to Content
Learn about the newest hep C treatment. Watch video >>

Telbivudine Pregnancy and Breastfeeding Warnings

Telbivudine is also known as: Tyzeka

Telbivudine Pregnancy Warnings

Telbivudine has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy. Telbivudine is only recommended for use during pregnancy when benefit outweighs risk.

Animal studies have shown that telbivudine crosses the placenta. A pregnancy registry has been established to monitor fetal outcomes of pregnant women exposed to telbivudine. Healthcare providers are encouraged to register patients by calling 1-800-258-4263 (USA).

See references

Telbivudine Breastfeeding Warnings

There are no data on the excretion of telbivudine into human milk. It is excreted into rat milk. The manufacturer advises against breast-feeding during telbivudine therapy.

See references

References for pregnancy information

  1. "Telbivudine (Tyzeka) for chronic Hepatitis B." Med Lett Drugs Ther 49 (2007): 11-2
  2. "Multum Information Services, Inc. Expert Review Panel"
  3. Matthews SJ "Telbivudine for the management of chronic hepatitis B virus infection." Clin Ther 29 (2007): 2635-53
  4. "Product Information. Tyzeka (telbivudine)." IDEC Pharmaceuticals Corporation, San Diego, CA.
  5. Keam SJ "Telbivudine." Drugs 67 (2007): 1917-29

References for breastfeeding information

  1. "Product Information. Tyzeka (telbivudine)." IDEC Pharmaceuticals Corporation, San Diego, CA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.